Aptose Announces Proposed Public Offering of Common Shares

Jul 15, 2020 4:01pm EDT

Aptose Announces FDA Allowance of IND for Phase 1a/b Study of CG-806 in Acute Myeloid Leukemia

Jun 29, 2020 7:01am EDT

Aptose Presents Early Phase 1a/b CG-806 Clinical Findings at the 25th Congress of the European Hematology Association

Jun 12, 2020 7:00am EDT

Aptose Biosciences Announces Results of Annual Meeting of Shareholders

Jun 02, 2020 5:49pm EDT

Aptose to Present Early CG-806 Clinical Findings at the 25th Congress of the European Hematology Association

May 14, 2020 9:00am EDT

Aptose to Present at 2020 RBC Capital Markets Global Healthcare Virtual Conference

May 07, 2020 7:30am EDT

Aptose Biosciences Establishes New At-The-Market Facility

May 05, 2020 4:17pm EDT

Aptose Reports Results for the First Quarter 2020

May 05, 2020 4:00pm EDT

Aptose Presents Preliminary Clinical Data on CG-806 at AACR Virtual Annual Meeting 2020

Apr 27, 2020 9:00am EDT

Aptose Biosciences Files Proxy Statement, Announces Online Only Annual General Meeting

Apr 24, 2020 7:30am EDT